Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.

[1]  MD Yu-Ning Wong,et al.  Survival associated with treatment vs observation of localized prostate cancer in elderly men. , 2006, JAMA.

[2]  M. Menon,et al.  Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). , 2006, Urology.

[3]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  K. Dieckmann,et al.  Long-Term Results in Three-Dimensional Conformal Radiotherapy of Localized Prostate Cancer at Moderate Dose (66 Gy) , 2006, Strahlentherapie und Onkologie.

[5]  D. Gandara,et al.  2006 Highlights From: 42nd Annual Meeting of the American Society of Clinical Oncology Atlanta, GA, June 2006 , 2006 .

[6]  M. Brundage,et al.  Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent , 2006, Cancer.

[7]  P. Carroll,et al.  Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. , 2006, Urology.

[8]  P. Scardino.  Update: NCCN prostate cancer Clinical Practice Guidelines. , 2005, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  Michael W Kattan,et al.  Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[11]  J. Hanley,et al.  20-year outcomes following conservative management of clinically localized prostate cancer. , 2005, JAMA.

[12]  T. Panzarella,et al.  Accuracy of survival prediction by palliative radiation oncologists. , 2005, International journal of radiation oncology, biology, physics.

[13]  E. Arias,et al.  United States life tables, 2002. , 2004, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[14]  M. Menon,et al.  Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. , 2004, The Journal of urology.

[15]  J. Fulton,et al.  Prostate Cancer Incidence and Mortality Rates and Trends in the United States and Canada , 2004, Public health reports.

[16]  G. Naglie,et al.  Do older men benefit from curative therapy of localized prostate cancer? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Kattan.  Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer , 2003, Current opinion in urology.

[18]  H. Ruchlin,et al.  An economic overview of prostate carcinoma , 2001, Cancer.

[19]  M Jones,et al.  Accuracy of point predictions in survival analysis , 2001, Statistics in medicine.

[20]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[21]  A. Zietman,et al.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. , 2000, JAMA.

[22]  W. Catalona,et al.  Primary treatment choices for men with clinically localized prostate carcinoma detected by screening , 2000, Cancer.

[23]  J. Fowler,et al.  Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. , 1996, The Journal of urology.

[24]  D. Fryback,et al.  The impact of co-morbidity on life expectancy among men with localized prostate cancer. , 1996, The Journal of urology.

[25]  D. Fryback,et al.  Long-term survival among men with conservatively treated localized prostate cancer. , 1995, JAMA.

[26]  C. Tilquin,et al.  Risk Adjustment in Outcome Assessment: the Charlson Comorbidity Index , 1993, Methods of Information in Medicine.

[27]  S Greenfield,et al.  The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement: Comorbidity and Outcomes After Hip Replacement , 1993, Medical care.

[28]  Sati Mazumdar,et al.  Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.

[29]  A. Feinstein,et al.  The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. , 1974, Journal of chronic diseases.

[30]  M. Cowen,et al.  Predicting life expectancy in men with clinically localized prostate cancer. , 2006, The Journal of urology.

[31]  S Vijayakumar,et al.  The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer , 2005, Prostate Cancer and Prostatic Diseases.

[32]  Gary Naglie,et al.  Is there age bias in the treatment of localized prostate carcinoma? , 2004, Cancer.

[33]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.

[34]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.